Cold & Cough Remedies - Jordan

  • Jordan
  • In the year 2024, the revenue generated in the Cold & Cough Remedies market market in Jordan amounts to US$26.97m.
  • It is projected that this market will experience an annual growth rate of 8.17% (CAGR 2024-2029).
  • When compared to other countries globally, the in the United States leads the way in terms of revenue generation, with a total revenue of US$11,190.00m in 2024.
  • In relation to the total population figures, the per person revenue generated in Jordan amounts to US$2.37 in 2024.
  • Sales of over-the-counter cold and cough remedies in Jordan have seen a significant increase in recent months due to the high prevalence of respiratory infections in the country.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Jordan has been experiencing steady growth in recent years.

Customer preferences:
Customers in Jordan have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience and accessibility of these products. Many consumers prefer to treat their symptoms at home rather than visiting a healthcare professional, and over-the-counter remedies provide a convenient solution. Additionally, the affordability of these products compared to prescription medications is also a key factor driving customer preferences.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Jordan is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about the ingredients used in the products they consume and are seeking natural alternatives to traditional medications. This trend is driven by a growing awareness of the potential side effects of certain chemicals and a desire for more holistic approaches to healthcare.Another trend in the market is the rising demand for combination products that offer relief from multiple symptoms. Cold and cough symptoms often overlap, and consumers are looking for products that can address multiple symptoms simultaneously. Combination products that offer relief from congestion, cough, and sore throat, for example, are becoming increasingly popular among consumers.

Local special circumstances:
One of the unique factors influencing the Cold & Cough Remedies market in Jordan is the country's climate. Jordan experiences hot and dry summers, which can lead to a higher prevalence of respiratory infections during the cooler months. This creates a higher demand for cold and cough remedies during the winter season.Additionally, the cultural practices and traditions in Jordan also play a role in shaping customer preferences. Traditional herbal remedies have a long history in Jordanian culture, and many consumers still rely on these remedies for treating cold and cough symptoms. This cultural influence contributes to the demand for natural and herbal products in the market.

Underlying macroeconomic factors:
The growing population and increasing disposable income in Jordan are key macroeconomic factors driving the growth of the Cold & Cough Remedies market. As the population continues to expand, the demand for healthcare products, including cold and cough remedies, is expected to increase. Rising disposable income levels also enable consumers to spend more on healthcare and wellness products, further fueling market growth.In conclusion, the Cold & Cough Remedies market in Jordan is experiencing steady growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the unique local circumstances of the country. The underlying macroeconomic factors, such as population growth and rising disposable income, also contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)